BioNTech SE: Form 20-F for the period ended Dec 31, 2024
Filed with the SEC on Mar 10, 2025 and accepted by EDGAR at Mar 10, 2025, 07:00 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2024-01-01 to 2024-12-31 | EUR 2.75bn | ifrs-full:RevenueFromContractsWithCustomers |
| Cost of revenue | 12 months2024-01-01 to 2024-12-31 | EUR 541.3m | ifrs-full:CostOfSales |
| Operating income | 12 months2024-01-01 to 2024-12-31 | −EUR 1.31bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2024-01-01 to 2024-12-31 | −EUR 12.4m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2024-01-01 to 2024-12-31 | −EUR 665.3m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months2024-01-01 to 2024-12-31 | −EUR 2.77 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2024-01-01 to 2024-12-31 | −EUR 2.77 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2024-01-01 to 2024-12-31 | EUR 207.7m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2024-01-01 to 2024-12-31 | EUR 286.5m | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2024-12-31 | EUR 9.76bn | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2024-12-31 | EUR 18.80bn | ifrs-full:CurrentAssets |
| Total assets | At period end2024-12-31 | EUR 22.53bn | ifrs-full:Assets |
| Current liabilities | At period end2024-12-31 | EUR 2.52bn | ifrs-full:CurrentLiabilities |
| Total liabilities | At period end2024-12-31 | EUR 3.12bn | ifrs-full:Liabilities |
| Shareholders' equity | At period end2024-12-31 | EUR 19.41bn | ifrs-full:Equity |
Source: SEC EDGAR, the filing index for accession 0001776985-25-000013. Last ingested by Listed: Nov 3, 2026, 08:40 ET. Listed shows no prices and gives no investment advice.